XTX Topco’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,928
| Closed | -$305K | – | 3032 |
|
|
2025
Q1 | $305K | Buy |
16,928
+6,018
| +55% | +$108K | 0.02% | 1398 |
|
|
2024
Q4 | $184K | Buy |
+10,910
| New | +$184K | 0.02% | 1577 |
|
|
2024
Q3 | – | Sell |
-28,515
| Closed | -$234K | – | 2513 |
|
|
2024
Q2 | $234K | Sell |
28,515
-2,942
| -9% | -$24.2K | 0.02% | 1123 |
|
|
2024
Q1 | $466K | Buy |
31,457
+25,889
| +465% | +$383K | 0.06% | 531 |
|
|
2023
Q4 | $80.7K | Sell |
5,568
-10,856
| -66% | -$157K | 0.02% | 1153 |
|
|
2023
Q3 | $177K | Buy |
16,424
+10,778
| +191% | +$116K | 0.03% | 1056 |
|
|
2023
Q2 | $72.8K | Sell |
5,646
-26,033
| -82% | -$336K | 0.01% | 1200 |
|
|
2023
Q1 | $418K | Buy |
31,679
+29,588
| +1,415% | +$391K | 0.09% | 407 |
|
|
2022
Q4 | $31.4K | Sell |
2,091
-42,381
| -95% | -$636K | 0.01% | 1064 |
|
|
2022
Q3 | $525K | Buy |
44,472
+30,253
| +213% | +$357K | 0.13% | 223 |
|
|
2022
Q2 | $161K | Buy |
14,219
+13,199
| +1,294% | +$149K | 0.07% | 519 |
|
|
2022
Q1 | $30K | Sell |
1,020
-3,306
| -76% | -$97.2K | 0.01% | 621 |
|
|
2021
Q4 | $115K | Buy |
+4,326
| New | +$115K | 0.07% | 445 |
|
|
2021
Q3 | – | Sell |
-3,688
| Closed | -$160K | – | 1007 |
|
|
2021
Q2 | $160K | Buy |
+3,688
| New | +$160K | 0.05% | 593 |
|